25 results on '"Shiah, H-S."'
Search Results
2. 1017P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (chemo) in patients (pts) with metastatic squamous (sq) and non-squamous (non-sq) non-small cell lung cancer (NSCLC)
3. Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
4. 1208P Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)
5. 1533P Advantig-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (CT) in patients (pts) with metastatic oesophageal squamous cell carcinoma (ESCC) and oesophageal adenocarcinoma (EAC)
6. A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
7. 397P A phase I cohort expansion trial of OBI-833 in non-small cell lung cancer patients
8. 71MO OBI-833 was safe and immunogenic, without treatment-related SAEs, in a phase I dose-escalation trial
9. Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
10. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23
11. Safety and efficacy of anti-PD-1 inhibitor ABBV-181 in lung and head and neck carcinoma
12. Pulmonary embolism after transcatheter arterial chemoembolization
13. α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma
14. erbB2 amplification associated with low thymidylate synthase expression in advanced gastric cancer is predictive of prolonged survival after high dose infusion 5-fluorouracil chemotherapy
15. Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients
16. 1288P - Safety and efficacy of anti-PD-1 inhibitor ABBV-181 in lung and head and neck carcinoma
17. 287PD - Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients
18. Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
19. Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)
20. 292 POSTER D501036, a novel selenophene-base triheterocycle derivative, exhibits potnt in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation
21. alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma
22. Modulatory effect of crocetin on aflatoxin B1 cytotoxicity and DNA adduct formation in C3H10T12 fibroblast cell
23. Effective sirolimus treatment for refractory spindle cell haemangioma.
24. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
25. Effect of ethanol on hepatotoxicity and hepatic DNA-binding of aflatoxin B1 in rats.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.